Guillermo Pérez-Hernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Guillermo Pérez-Hernández has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
- Leticia González
University of Vienna
9 shared publications - Peter Werner Hildebrand
Institute of Medical Physics and Biophysics, Medical Faculty, Leipzig University, Leipzig, Germany
8 shared publications - Brian K. Kobilka
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA
5 shared publications - Ramon Guixà-González
Paul Scherrer Institute
5 shared publications - Andrea Volkamer
Data Driven Drug Design, Center for Bioinformatics, Saarland Informatics Campus, Saarland University, PharmaScienceHub (PSH), 66123 Saarbrücken, Germany
3 shared publications - Frank Noé
Freie Universität Berlin
3 shared publications
Latest Publications
- Open Access
- 26 April 2026
- Published by Elsevier in Artificial Intelligence in the Life Sciences
- Vol. 9
Evaluation beyond goodness of fit: Quantifying biophysical alignment of AI models for kinase-centric drug discovery
- 26 April 2026
- Published by Elsevier in Artificial Intelligence in the Life Sciences
- Vol. 9
Open AccessEvaluation beyond goodness of fit: Quantifying biophysical alignment of AI models for kinase-centric drug discovery
- Open Access
- 21 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Evaluation Beyond Goodness of Fit: Biophysical Alignment of AI Models for Kinase-Centric Drug Discovery
Accurately modeling interactions between small molecules and proteins using machine learning (ML) remains a central challenge in modern drug discovery. In particular, achieving and reliably assessing generalization in ML-based mod- els for binding affinity prediction has proven difficult. Focusing on the protein kinase domain, we investigate both the predictive performance and biophysical plausibility of graph neural networks (GNNs) trained to predict binding affinity, with and without access to docked protein–ligand complexes. To this end, we introduce a model-agnostic explainable AI framework that interprets model pre- dictions by attributing them to specific residues within the ATP-binding pocket of kinases. On the basis of discrete interaction fingerprints (IFPs), we employ robust statistical methods and feature selection to derive reference interaction profiles that serve as ground-truth explanations. Our analysis identifies 131 dis- tinct residues across 29 unique kinases that play key roles in linking IFP and binding affinity data. This enables a complementary benchmark, spanning nearly 10,000 docked complexes, to quantitatively assess model quality not only in terms of predictive accuracy but also biophysical alignment. The benchmark quantifies to what extent the model’s predictive mechanism aligns with meaningful bio- physical mechanisms—specifically, whether it recognizes protein regions actively involved in ligand binding. In a pilot study, we find that models incorporating 3D structural features exhibit moderate biophysical alignment, whereas baseline models without 3D information show no significant alignment, underscoring the structural nature of molecular binding, and importance thereof for training GNN models.
- 21 November 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessEvaluation Beyond Goodness of Fit: Biophysical Alignment of AI Models for Kinase-Centric Drug Discovery
Accurately modeling interactions between small molecules and proteins using machine learning (ML) remains a central challenge in modern drug discovery. In particular, achieving and reliably assessing generalization in ML-based mod- els for binding affinity prediction has proven difficult. Focusing on the protein kinase domain, we investigate both the predictive performance and biophysical plausibility of graph neural networks (GNNs) trained to predict binding affinity, with and without access to docked protein–ligand complexes. To this end, we introduce a model-agnostic explainable AI framework that interprets model pre- dictions by attributing them to specific residues within the ATP-binding pocket of kinases. On the basis of discrete interaction fingerprints (IFPs), we employ robust statistical methods and feature selection to derive reference interaction profiles that serve as ground-truth explanations. Our analysis identifies 131 dis- tinct residues across 29 unique kinases that play key roles in linking IFP and binding affinity data. This enables a complementary benchmark, spanning nearly 10,000 docked complexes, to quantitatively assess model quality not only in terms of predictive accuracy but also biophysical alignment. The benchmark quantifies to what extent the model’s predictive mechanism aligns with meaningful bio- physical mechanisms—specifically, whether it recognizes protein regions actively involved in ligand binding. In a pilot study, we find that models incorporating 3D structural features exhibit moderate biophysical alignment, whereas baseline models without 3D information show no significant alignment, underscoring the structural nature of molecular binding, and importance thereof for training GNN models.
- Open Access
- 12 July 2025
- Published by University of Colorado at Boulder in Living Journal of Computational Molecular Science
- Vol. 6 (1)
The Journey of Data: Lessons Learned in Modeling Kinase Affinity, Selectivity, and Resistance [Article v1.0]
Recent advances in machine learning (ML) are reshaping drug discovery. Structure-based ML methods use physically-inspired models to predict binding affinities from protein:ligand complexes. These methods promise to enable the integration of data for many related targets, which addresses issues related to data scarcity for single targets and could enable generalizable predictions for a broad range of targets, including mutations. In this work, we report our experiences in building KinoML, a novel framework for ML in target-based small molecule drug discovery with an emphasis on structure-enabled methods. KinoML focuses currently on kinases as the relative structural conservation of this protein superfamily, particularly in the kinase domain, means it is possible to leverage data from the entire superfamily to make structure-informed predictions about binding affinities, selectivities, and drug resistance. Some key lessons learned in building KinoML include the importance of reproducible data collection and deposition, the harmonization of molecular data and featurization, and the selection of the right data format to ensure reusability and reproducibility of ML models. As a result, KinoML allows users to easily achieve three tasks: accessing and curating molecular data; featurizing this data with representations suitable for ML applications; and running reproducible ML experiments that require access to ligand, protein, and assay information to predict ligand affinity. Despite KinoML focusing on kinases, this framework can be applied to other proteins. The lessons reported here can help guide the development of platforms for structure-enabled ML in other areas of drug discovery.
- 12 July 2025
- Published by University of Colorado at Boulder in Living Journal of Computational Molecular Science
- Vol. 6 (1)
Open AccessThe Journey of Data: Lessons Learned in Modeling Kinase Affinity, Selectivity, and Resistance [Article v1.0]
Recent advances in machine learning (ML) are reshaping drug discovery. Structure-based ML methods use physically-inspired models to predict binding affinities from protein:ligand complexes. These methods promise to enable the integration of data for many related targets, which addresses issues related to data scarcity for single targets and could enable generalizable predictions for a broad range of targets, including mutations. In this work, we report our experiences in building KinoML, a novel framework for ML in target-based small molecule drug discovery with an emphasis on structure-enabled methods. KinoML focuses currently on kinases as the relative structural conservation of this protein superfamily, particularly in the kinase domain, means it is possible to leverage data from the entire superfamily to make structure-informed predictions about binding affinities, selectivities, and drug resistance. Some key lessons learned in building KinoML include the importance of reproducible data collection and deposition, the harmonization of molecular data and featurization, and the selection of the right data format to ensure reusability and reproducibility of ML models. As a result, KinoML allows users to easily achieve three tasks: accessing and curating molecular data; featurizing this data with representations suitable for ML applications; and running reproducible ML experiments that require access to ligand, protein, and assay information to predict ligand affinity. Despite KinoML focusing on kinases, this framework can be applied to other proteins. The lessons reported here can help guide the development of platforms for structure-enabled ML in other areas of drug discovery.
- Open Access
- 21 April 2025
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 21 (4) , e1012837
mdciao: Accessible Analysis and Visualization of Molecular Dynamics Simulation Data
We present mdciao, an open-source command line tool and Python Application-Programming-Interface (API) for easy, one-shot analysis and representation of molecular dynamics (MD) simulation data. Building upon the widely used concept of residue-residue contact-frequencies, mdciao offers a wide spectrum of further analysis and representations, enriched with available domain specific annotations. The user-friendly interface offers pre-packaged solutions for non-expert users, while keeping customizability for expert ones. Emphasis has been put into automatically producing annotated, production-ready figures and tables. Furthermore, seamless on-the-fly query and inclusion of domain-specific generic residue numbering for GPCRs, GAIN-domains, G-proteins, and kinases is made possible through online lookups. This allows for easy selection and comparison across different systems, regardless of sequence identity, target residues or domains. Finally, the fully documented Python API allows users to include the basic or advanced mdciao functions in their analysis workflows, and provides numerous examples and Jupyter Notebook Tutorials. The source code is published under the GNU Lesser General Public License v3.0 or later and hosted on https://github.com/gph82/mdciao, and the documentation, including guides and examples, can be found at https://www.mdciao.org
- 21 April 2025
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 21 (4) , e1012837
Open Accessmdciao: Accessible Analysis and Visualization of Molecular Dynamics Simulation Data
We present mdciao, an open-source command line tool and Python Application-Programming-Interface (API) for easy, one-shot analysis and representation of molecular dynamics (MD) simulation data. Building upon the widely used concept of residue-residue contact-frequencies, mdciao offers a wide spectrum of further analysis and representations, enriched with available domain specific annotations. The user-friendly interface offers pre-packaged solutions for non-expert users, while keeping customizability for expert ones. Emphasis has been put into automatically producing annotated, production-ready figures and tables. Furthermore, seamless on-the-fly query and inclusion of domain-specific generic residue numbering for GPCRs, GAIN-domains, G-proteins, and kinases is made possible through online lookups. This allows for easy selection and comparison across different systems, regardless of sequence identity, target residues or domains. Finally, the fully documented Python API allows users to include the basic or advanced mdciao functions in their analysis workflows, and provides numerous examples and Jupyter Notebook Tutorials. The source code is published under the GNU Lesser General Public License v3.0 or later and hosted on https://github.com/gph82/mdciao, and the documentation, including guides and examples, can be found at https://www.mdciao.org
- Open Access
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Generic residue numbering of the GAIN domain of adhesion GPCRs
The GPCR autoproteolysis inducing (GAIN) domain is an ancient protein fold ubiquitous in adhesion G protein-coupled receptors (aGPCR). It contains a tethered agonist necessary and sufficient for receptor activation. The GAIN domain is a hotspot for pathological mutations. However, the low primary sequence conservation of GAIN domains has thus far hindered the knowledge transfer across different GAIN domains in human receptors as well as species orthologs. Here, we present a scheme for generic residue numbering of GAIN domains, based on structural alignments of over 14,000 modeled GAIN domain structures. This scheme is implemented in the GPCR database (GPCRdb) and elucidates the domain topology across different aGPCRs and their homologs in a large panel of species. We identify conservation hotspots and statistically cancer-enriched positions in human aGPCRs and show the transferability of positional and structural information between GAIN domain homologs. The GAIN-GRN scheme provides a robust strategy to allocate structural homologies at the primary and secondary levels also to GAIN domains of polycystic kidney disease 1/PKD1-like proteins, which now renders positions in both GAIN domain types comparable to one another. In summary, our work enables researchers to generate hypothesis and rationalize experiments related to GAIN domain function and pathology.
- 2 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Open AccessGeneric residue numbering of the GAIN domain of adhesion GPCRs
The GPCR autoproteolysis inducing (GAIN) domain is an ancient protein fold ubiquitous in adhesion G protein-coupled receptors (aGPCR). It contains a tethered agonist necessary and sufficient for receptor activation. The GAIN domain is a hotspot for pathological mutations. However, the low primary sequence conservation of GAIN domains has thus far hindered the knowledge transfer across different GAIN domains in human receptors as well as species orthologs. Here, we present a scheme for generic residue numbering of GAIN domains, based on structural alignments of over 14,000 modeled GAIN domain structures. This scheme is implemented in the GPCR database (GPCRdb) and elucidates the domain topology across different aGPCRs and their homologs in a large panel of species. We identify conservation hotspots and statistically cancer-enriched positions in human aGPCRs and show the transferability of positional and structural information between GAIN domain homologs. The GAIN-GRN scheme provides a robust strategy to allocate structural homologies at the primary and secondary levels also to GAIN domains of polycystic kidney disease 1/PKD1-like proteins, which now renders positions in both GAIN domain types comparable to one another. In summary, our work enables researchers to generate hypothesis and rationalize experiments related to GAIN domain function and pathology.
- Open Access
- 19 July 2024
- Published by Springer Nature in Research Square
Generic residue numbering of the GAIN domain of adhesion GPCRs
The GPCR autoproteolysis inducing (GAIN) domain is an ancient protein fold ubiquitous in adhesion G protein-coupled receptors (aGPCR). It contains a concealed tethered agonist element, which is necessary and sufficient for receptor activation. The GAIN domain is a hotspot for pathological mutations. However, the low primary sequence conservation of GAIN domains has thus far hindered the knowledge transfer across different GAIN domains in human receptors as well as species orthologs. Here, we present a scheme for generic residue numbering of GAIN domains based on structural alignments of six experimental and more than 14,000 modeled GAIN domain structures. This scheme is implemented in the GPCR database (GPCRdb) and elucidates the domain topology across different aGPCRs and their homologs in a large panel of species. We identify conservation hotspots and cancer-enriched positions in human aGPCRs and show the transferability of positional and structural information between GAIN domain homologs. The GAIN-GRN scheme provides a robust strategy to allocate structural homologies at the primary and secondary levels also to GAIN folds of GAIN domains of polycystic kidney disease 1/PKD1-like proteins, which now renders positions in both GAIN domain types comparable to one another.
- 19 July 2024
- Published by Springer Nature in Research Square
Open AccessGeneric residue numbering of the GAIN domain of adhesion GPCRs
The GPCR autoproteolysis inducing (GAIN) domain is an ancient protein fold ubiquitous in adhesion G protein-coupled receptors (aGPCR). It contains a concealed tethered agonist element, which is necessary and sufficient for receptor activation. The GAIN domain is a hotspot for pathological mutations. However, the low primary sequence conservation of GAIN domains has thus far hindered the knowledge transfer across different GAIN domains in human receptors as well as species orthologs. Here, we present a scheme for generic residue numbering of GAIN domains based on structural alignments of six experimental and more than 14,000 modeled GAIN domain structures. This scheme is implemented in the GPCR database (GPCRdb) and elucidates the domain topology across different aGPCRs and their homologs in a large panel of species. We identify conservation hotspots and cancer-enriched positions in human aGPCRs and show the transferability of positional and structural information between GAIN domain homologs. The GAIN-GRN scheme provides a robust strategy to allocate structural homologies at the primary and secondary levels also to GAIN folds of GAIN domains of polycystic kidney disease 1/PKD1-like proteins, which now renders positions in both GAIN domain types comparable to one another.
- 12 June 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 31 (11) , 1692-1701
Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor
G-protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by promoting guanine nucleotide exchange. Here, we investigate the coupling of G proteins with GPCRs and describe the events that ultimately lead to the ejection of GDP from its binding pocket in the Gα subunit, the rate-limiting step during G-protein activation. Using molecular dynamics simulations, we investigate the temporal progression of structural rearrangements of GDP-bound Gs protein (Gs·GDP; hereafter GsGDP) upon coupling to the β2-adrenergic receptor (β2AR) in atomic detail. The binding of GsGDP to the β2AR is followed by long-range allosteric effects that significantly reduce the energy needed for GDP release: the opening of α1-αF helices, the displacement of the αG helix and the opening of the α-helical domain. Signal propagation to the Gs occurs through an extended receptor interface, including a lysine-rich motif at the intracellular end of a kinked transmembrane helix 6, which was confirmed by site-directed mutagenesis and functional assays. From this β2AR–GsGDP intermediate, Gs undergoes an in-plane rotation along the receptor axis to approach the β2AR–Gsempty state. The simulations shed light on how the structural elements at the receptor–G-protein interface may interact to transmit the signal over 30 Å to the nucleotide-binding site. Our analysis extends the current limited view of nucleotide-free snapshots to include additional states and structural features responsible for signaling and G-protein coupling specificity.
- 12 June 2024
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 31 (11) , 1692-1701
Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor
G-protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by promoting guanine nucleotide exchange. Here, we investigate the coupling of G proteins with GPCRs and describe the events that ultimately lead to the ejection of GDP from its binding pocket in the Gα subunit, the rate-limiting step during G-protein activation. Using molecular dynamics simulations, we investigate the temporal progression of structural rearrangements of GDP-bound Gs protein (Gs·GDP; hereafter GsGDP) upon coupling to the β2-adrenergic receptor (β2AR) in atomic detail. The binding of GsGDP to the β2AR is followed by long-range allosteric effects that significantly reduce the energy needed for GDP release: the opening of α1-αF helices, the displacement of the αG helix and the opening of the α-helical domain. Signal propagation to the Gs occurs through an extended receptor interface, including a lysine-rich motif at the intracellular end of a kinked transmembrane helix 6, which was confirmed by site-directed mutagenesis and functional assays. From this β2AR–GsGDP intermediate, Gs undergoes an in-plane rotation along the receptor axis to approach the β2AR–Gsempty state. The simulations shed light on how the structural elements at the receptor–G-protein interface may interact to transmit the signal over 30 Å to the nucleotide-binding site. Our analysis extends the current limited view of nucleotide-free snapshots to include additional states and structural features responsible for signaling and G-protein coupling specificity.
- Top Cited Papers
- 13 March 2024
- Published by Springer Nature in Nature
- Vol. 629 (8014) , 1182-1191
Time-resolved cryo-EM of G-protein activation by a GPCR
G-protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by stimulating guanine nucleotide exchange in the Gα subunit1. To visualize this mechanism, we developed a time-resolved cryo-EM approach that examines the progression of ensembles of pre-steady-state intermediates of a GPCR–G-protein complex. By monitoring the transitions of the stimulatory Gs protein in complex with the β2-adrenergic receptor at short sequential time points after GTP addition, we identified the conformational trajectory underlying G-protein activation and functional dissociation from the receptor. Twenty structures generated from sequential overlapping particle subsets along this trajectory, compared to control structures, provide a high-resolution description of the order of main events driving G-protein activation in response to GTP binding. Structural changes propagate from the nucleotide-binding pocket and extend through the GTPase domain, enacting alterations to Gα switch regions and the α5 helix that weaken the G-protein–receptor interface. Molecular dynamics simulations with late structures in the cryo-EM trajectory support that enhanced ordering of GTP on closure of the α-helical domain against the nucleotide-bound Ras-homology domain correlates with α5 helix destabilization and eventual dissociation of the G protein from the GPCR. These findings also highlight the potential of time-resolved cryo-EM as a tool for mechanistic dissection of GPCR signalling events.
- 13 March 2024
- Published by Springer Nature in Nature
- Vol. 629 (8014) , 1182-1191
Top Cited PapersTime-resolved cryo-EM of G-protein activation by a GPCR
G-protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by stimulating guanine nucleotide exchange in the Gα subunit1. To visualize this mechanism, we developed a time-resolved cryo-EM approach that examines the progression of ensembles of pre-steady-state intermediates of a GPCR–G-protein complex. By monitoring the transitions of the stimulatory Gs protein in complex with the β2-adrenergic receptor at short sequential time points after GTP addition, we identified the conformational trajectory underlying G-protein activation and functional dissociation from the receptor. Twenty structures generated from sequential overlapping particle subsets along this trajectory, compared to control structures, provide a high-resolution description of the order of main events driving G-protein activation in response to GTP binding. Structural changes propagate from the nucleotide-binding pocket and extend through the GTPase domain, enacting alterations to Gα switch regions and the α5 helix that weaken the G-protein–receptor interface. Molecular dynamics simulations with late structures in the cryo-EM trajectory support that enhanced ordering of GTP on closure of the α-helical domain against the nucleotide-bound Ras-homology domain correlates with α5 helix destabilization and eventual dissociation of the G protein from the GPCR. These findings also highlight the potential of time-resolved cryo-EM as a tool for mechanistic dissection of GPCR signalling events.
- Open Access
- 13 June 2023
- Published by Springer Nature in Research Square
Mechanistic insights into G protein association with a G protein-coupled receptor
G protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by promoting guanine nucleotide exchange. Here, we investigate the process of functional association between G proteins and GPCRs and describe the events that ultimately lead to the ejection of GDP from its binding pocket in the Gα subunit. In atomic detail, we reveal the temporal progression of structural rearrangements of GDP-bound heterotrimeric Gs protein (GsGDP) upon coupling to the β2-adrenergic receptor (β2AR) using molecular dynamics simulations. The binding of GsGDP to the β2AR is followed by long-range allosteric effects that significantly reduce the energy needed for GDP release, the rate-limiting step during G-protein activation. In particular, the opening of α1-αF helices, displacement of the αG helix, and the opening of the α-helical domain weaken the interaction between GDP and the G protein. Signal transduction to the G protein occurs via a novel receptor interface, confirmed by site-directed mutagenesis and functional assays. From this β2AR-GsGDP intermediate, the G protein must undergo an in-plane rotation along the receptor axis to reach the β2AR-Gsempty state. The simulations shed light on how the structural elements at the receptor-G-protein interface interact to transmit the signal over 30Å to the nucleotide-binding site. Our analysis extends the current limited view of nucleotide-free snapshots to include additional states and structural features responsible for signaling and G protein coupling specificity.
- 13 June 2023
- Published by Springer Nature in Research Square
Open AccessMechanistic insights into G protein association with a G protein-coupled receptor
G protein-coupled receptors (GPCRs) activate heterotrimeric G proteins by promoting guanine nucleotide exchange. Here, we investigate the process of functional association between G proteins and GPCRs and describe the events that ultimately lead to the ejection of GDP from its binding pocket in the Gα subunit. In atomic detail, we reveal the temporal progression of structural rearrangements of GDP-bound heterotrimeric Gs protein (GsGDP) upon coupling to the β2-adrenergic receptor (β2AR) using molecular dynamics simulations. The binding of GsGDP to the β2AR is followed by long-range allosteric effects that significantly reduce the energy needed for GDP release, the rate-limiting step during G-protein activation. In particular, the opening of α1-αF helices, displacement of the αG helix, and the opening of the α-helical domain weaken the interaction between GDP and the G protein. Signal transduction to the G protein occurs via a novel receptor interface, confirmed by site-directed mutagenesis and functional assays. From this β2AR-GsGDP intermediate, the G protein must undergo an in-plane rotation along the receptor axis to reach the β2AR-Gsempty state. The simulations shed light on how the structural elements at the receptor-G-protein interface interact to transmit the signal over 30Å to the nucleotide-binding site. Our analysis extends the current limited view of nucleotide-free snapshots to include additional states and structural features responsible for signaling and G protein coupling specificity.
- Open Access
- 10 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Function and dynamics of the intrinsically disordered carboxyl terminus of β2 adrenergic receptor
Advances in structural biology have provided important mechanistic insights into signaling by the transmembrane core of G-protein coupled receptors (GPCRs); however, much less is known about intrinsically disordered regions such as the carboxyl terminus (CT), which is highly flexible and not visible in GPCR structures. The β2adrenergic receptor’s (β2AR) 71 amino acid CT is a substrate for GPCR kinases and binds β-arrestins to regulate signaling. Here we show that the β2AR CT directly inhibits basal and agonist-stimulated signaling in cell lines lacking β-arrestins. Combining single-molecule fluorescence resonance energy transfer (FRET), NMR spectroscopy, and molecular dynamics simulations, we reveal that the negatively charged β2AR-CT serves as an autoinhibitory factor via interacting with the positively charged cytoplasmic surface of the receptor to limit access to G-proteins. The stability of this interaction is influenced by agonists and allosteric modulators, emphasizing that the CT plays important role in allosterically regulating GPCR activation.
- 10 April 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-18
Open AccessFunction and dynamics of the intrinsically disordered carboxyl terminus of β2 adrenergic receptor
Advances in structural biology have provided important mechanistic insights into signaling by the transmembrane core of G-protein coupled receptors (GPCRs); however, much less is known about intrinsically disordered regions such as the carboxyl terminus (CT), which is highly flexible and not visible in GPCR structures. The β2adrenergic receptor’s (β2AR) 71 amino acid CT is a substrate for GPCR kinases and binds β-arrestins to regulate signaling. Here we show that the β2AR CT directly inhibits basal and agonist-stimulated signaling in cell lines lacking β-arrestins. Combining single-molecule fluorescence resonance energy transfer (FRET), NMR spectroscopy, and molecular dynamics simulations, we reveal that the negatively charged β2AR-CT serves as an autoinhibitory factor via interacting with the positively charged cytoplasmic surface of the receptor to limit access to G-proteins. The stability of this interaction is influenced by agonists and allosteric modulators, emphasizing that the CT plays important role in allosterically regulating GPCR activation.